09.04.2012 - Carl Icahn sued Amylin Pharmaceuticals on Monday to extend a deadline for nominating directors, as the activist investor pushes to win enough board seats to engineer a sale of the...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)
